UK to speed up vaccinations, warns B.1.617.2 variant may delay full reopening 

Prime Minister Boris Johnson said on Friday Britain would accelerate its COVID-19 vaccination programme, to try to contain a fast-spreading variant first identified in India that could knock a re-opening of the economy off track. 

The United Kingdom has delivered one of the world's fastest inoculation campaigns, giving a first shot to almost 70% of the adult population and a second to 36%, helping to reduce infection rates and deaths. 

But the emergence of the B.1.617.2 variant in parts of northern England and London has prompted some scientists to call for the reopening to be delayed, and a rethink on the speed of the vaccine rollout.  

"I believe we should trust in our vaccines to protect the public whilst monitoring the situation very closely because the race between our vaccination programme and the virus may be about to become a great deal tighter," Johnson told a news conference. 

He said the government would accelerate remaining second doses to the over 50s and those clinically vulnerable to just eight weeks after the first dose, and would prioritise first doses for those eligible who had not yet come forward. 

Even so, the spread of the variant could disrupt Britain's progress out of lockdown, making it more difficult to move to the final stage of a staggered reopening of the economy in June, he said. 

Johnson had aimed to lift all restrictions on June 21, after allowing people in England from Monday to hug again, meet in small groups indoors and travel abroad. 

Chris Whitty, England chief medical officer, said there was now confidence that B.1.617.2 was more transmissible than the 'Kent' variant that fuelled England's second wave of infections. He said B.1.617.2 could come to dominate in Britain. 

Public Health England said on Thursday there had been 1,313 cases in England of B.1.617.2 in a week, more than double the previous week's figure, with four confirmed deaths. 

Whitty said so far there had not been a significant increase in hospitalisations from the variant, which may be because more people had been vaccinated. 

But both Johnson and Whitty said it was still early days, and scientists would need to scrutinise data over the next two or three weeks to truly see the impact of the variant. 

(With inputs from agencies)